GSK plc
SEC Form 4 insider trading activity
GSK plc has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 15, 2025.
On the most recent filing, GSK plc is listed as 10% Owner at Wave Life Sciences Ltd. Inside the rolling window, GSK plc reported 1 open-market purchase totaling $27.9M in WVE and no open-market sales.
Companies traded
Other insiders at WVE
Insider Buying
$27.9M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GSK plc made?
GSK plc has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does GSK plc trade?
GSK plc has filed SEC Form 4 disclosures for 1 company, including WVE.
When was GSK plc's most recent SEC Form 4 filing?
GSK plc's most recent SEC Form 4 filing on Tracefour is dated Dec 15, 2025.
What is GSK plc's total buy and sell value in the current window?
Inside the rolling retention window, GSK plc bought $27.9M and sold $0 based on SEC Form 4 filings.
What was GSK plc's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,470,000 WVE shares on 2025-12-11, worth $27.9M, per SEC Form 4 filings.